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It Is Better to Flush than  
to Break under Pressure
Cynthia Bartus1 and Robert Swerlick1
In this issue Fromy et al. describe alterations in pressure-induced vasodilation 
in the populations most prone to development of pressure ulcers of the 
skin. Advancing our understanding regarding the basic pathophysiological 
mechanisms mediating the development of pressure ulcers will allow for 
better delineation of populations at risk. This study provides novel insights into 
this important and poorly understood entity, using tools that are potentially 
deployable into clinical practice.
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Pressure ulcers are a common and cost-
ly problem. The estimated incidence of 
pressure ulcers ranges from 0.4 to 38% 
in general acute care (hospitals), from 
2.2 to 23.9% in long-term care, and 
from 0 to 17% in home care (Cuddigan 
et al., 2001). The financial impact of 
pressure ulcers is substantial. The esti-
mated cost of healing a single pressure 
ulcer approaches $40,000 and rises if 
litigation costs are factored in (Lyder, 
2003; Voss et al., 2005).
Since the late 1950s, when the role 
of ischemia in pressure ulcer develop-
ment was first reported (Kosiak, 1959), 
elucidation of the pathophysiology of 
pressure ulcers and their treatment has 
advanced slowly. More than 100 risk 
factors for pressure ulcers have been 
described, supporting a multifactorial 
etiology. Prediction tools based on this 
broad range of risk factors have been 
employed to identify specific at-risk 
populations and to reduce the inci-
dence of pressure ulcers. However, 
these tools tend to overestimate risk, 
owing to the breadth of clinical cat-
egories used to identify at-risk patients, 
resulting in misdirected and wasted 
resources.
Significant study has further char-
acterized the pathogenesis of pressure 
ulcers based on a on a micro vascular 
target. Such fundamental work is 
essential to focus prediction tools on 
specific high-risk populations and 
scenarios and to improve ulcer clas-
sifications and tissue-injury models. 
Understanding the underlying processes 
in pressure ulcer development may ulti-
mately facilitate their prevention and 
treatment.
In this issue, Fromy et al. describe an 
elegant in vivo human model used to 
demonstrate the physiologic correlates 
of known epidemiologic risk factors for 
pressure ulcer development. Previous 
work by these authors identified a 
vasodilatory axon reflex response 
to nonnoxious pressure stimulation 
mediated by capsaicin-sensitive nerve 
terminals in human skin (pressure-
induced vasodilatation) (Fromy et al., 
1998). This pathway appears to func-
tion as a tissue-protective mechanism, 
increasing local blood flow to the skin 
in response to external pressure and 
delaying the deleterious effects of pres-
sure by preventing ischemia. Further 
work in animal models established 
the presence of this reflex in rats and 
revealed that local pressure stimulates 
the release of calcitonin gene-related 
peptide (a sensory neuropeptide) 
and neuronal nitric oxide by primary 
afferent nerves. These mediators then 
stimulate the release of endothelial 
nitric oxide, resulting in vascular 
smooth muscle relaxation. Later studies 
by Fromy et al. (2007) demonstrated 
a neuroendocrine-mediated loss of 
pressure-induced vasodilatation in 
rats subjected to acute pain. These 
physiologic experiments identified pain 
as an additional risk factor for pressure 
ulcers.
In their article in this issue, Fromy 
et al. report altered microcirculation 
in response to pressure in both neuro-
pathic and nonneuropathic older sub-
jects (60–75 years old) as compared 
with younger subjects (20–35 years 
old). Younger subjects demonstrated 
robust vasodilation after application 
of local pressure. Older subjects with-
out neuro pathy exhibited a markedly 
lower pressure-induced vaso dilatory 
response as compared with younger 
subjects. Furthermore, neuropathic 
older subjects lacked any pressure-
induced vaso dilatory response, 
demonstrating a decrease in cutane-
ous vascular conductance after pres-
sure application (Fromy et al., 2010). 
These findings provide a mechanism 
with which to explain the physi-
ologic decline of vascular responses 
with age and sensory deficits, result-
ing in a decreased ability to protect 
the skin from pressure-induced isch-
emia. The work provides direct in 
vivo physiologic data to support aging 
and neuro pathy as risk factors for the 
development of pressure ulcers. It also 
provides a useful framework in which 
to consider how advancing age and 
loss of neurologic function may alter 
vascular function in organs other than 
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understanding of the etiology and 
prevention of pressure ulcers of the 
skin. These methods and studies hold 
promise for identifying and treating 
those at risk for this costly and burden-
some disease.
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skin, and it may be clinically relevant 
in other disease processes, including 
cardiovascular disease, diabetes mel-
litus, Raynaud’s phenomenon, and 
erythromelalgia (Charkoudian, 2003).
The findings reported in this issue 
highlight the role of in vivo human 
studies in identifying physiologic 
mechanisms of disease and in valid-
ating work done in nonhuman models. 
The experiments emphasize the power 
of noninvasive study of the human 
cutaneous microcirculation with 
results that significantly improve our 
Clinical Implications
•  Understanding the underlying processes in pressure ulcer 
development may facilitate prevention and treatment.
•  Fromy et al. report altered microcirculation in response  
to pressure in older subjects as compared with younger subjects.
•  Aging and neuropathy are risk factors for the development  
of pressure ulcers.
